Disclosures for "Patient and Physician Perspectives on the Wearing-off Effect in Multiple Sclerosis: Results from Structured Interviews"
-
Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Motric Bio.
-
Joanne Fielding, 24833 has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . The institution of Joanne Fielding, 24833 has received research support from BioEye. The institution of Joanne Fielding, 24833 has received research support from Equity Trustees. The institution of Joanne Fielding, 24833 has received research support from Macquarie Group Foundation. The institution of Joanne Fielding, 24833 has received research support from Genzyme. The institution of Joanne Fielding, 24833 has received research support from Biogen. The institution of Joanne Fielding, 24833 has received research support from Open Medicines Australia. The institution of Joanne Fielding, 24833 has received research support from EyeOnVision.
-
Mr. Clement has received personal compensation for serving as an employee of Novartis. Mr. Clement has stock in Roche.
-
Ms. Khazaei has nothing to disclose.
-
Dr. Jimenez-Moreno has nothing to disclose.
-
Donald M. Bushnell has nothing to disclose.
-
Dr. Pata has received personal compensation for serving as an employee of Novartis .
-
Dr. Parratt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Parratt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Parratt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Parratt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Parratt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.